X0609 4 2026-05-21 0001682852 Moderna, Inc. MRNA 0001222012 AFEYAN NOUBAR false C/O FLAGSHIP PIONEERING 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142 true false false false false Common Stock 2026-05-21 4 M false 9263 19.15 A 13187 I By Flagship Pioneering, LLC Common Stock 2026-05-21 4 S false 9263 46.84 D 3924 I By Flagship Pioneering, LLC Common Stock 3880328 I By Flagship Ventures Fund IV, L.P. Common Stock 747897 I By Flagship Ventures Fund IV-Rx, L.P. Common Stock 2224015 D Stock Option (Right to Buy) 19.15 2026-05-21 4 M false 9263 0.00 D 2026-08-10 Common Stock 9263 0 I By Flagship Pioneering, LLC On May 21, 2026, Flagship Pioneering, LLC ("Flagship Pioneering") exercised options to purchase 9,263 shares of the Issuer's Common Stock at $19.15 per share, which options were set to expire on August 10, 2026. The securities are held directly by Flagship Pioneering. Flagship Pioneering is contractually obligated to transfer and/or remit the proceeds of any sale of shares to Flagship Fund IV, L.P. ("Flagship Fund IV"). The reporting person is the ultimate control person of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. The securities are held directly by Flagship Fund IV. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. The reporting person is the sole manager of Flagship Fund IV GP and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. The securities are held directly by Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. The options were fully vested and exercisable. Noubar B. Afeyan, Ph.D. By: /s/ Noubar B. Afeyan, Ph.D. 2026-05-22